In this episode, host Shikha Jain, MD, speaks with Maureen McBeth, PT, MPT, CLT-LANA, about understanding individualized patient experiences with lymphedema, the value of exercise oncology and more. • Welcome to another exciting episode of Oncology Overdrive 0:14 • About McBeth 0:23 • The interview 0:52 • How did you end up in the lymphedema and cancer rehab space? 1:31 • Why is lymphedema such a big topic, especially in the breast cancer space? 3:20 • Jain and McBeth on the complexities of individual lymphedema cases, including studies on lymphatic imaging. 5:25 • Do you feel like there have been advancements in the lymphedema space that can improve our understanding of it? 9:43 • Have stigmas around lymphedema evolved over the years? 12:31 • McBeth on the educational materials available to physicians surrounding cancer-related lymphedema and prospective surveillance. 15:15 • Tell us about ImpediMed and its purpose. 17:06 • How do you incorporate these technologies into the current dialogue about more holistic care? 21:27 • Jain and McBeth on exercise oncology and its impact on overall survival. 24:22 • In ten years, what would you envision as the future of lymphedema and exercise oncology? 29:01 • If someone could only listen to the last few minutes of this episode, what would you want listeners to take away? 32:31 • How to contact McBeth 33:33 • Thanks for listening 34:20

Maureen McBeth, PT, MPT, CLT-LANA, is a licensed physical therapist and certified lymphedema therapist with over 25 years of experience in oncology rehabilitation, clinical education, and patient advocacy. She currently serves as senior medical affairs liaison at ImpediMed.

We'd love to hear from you! Send your comments/questions to Dr. Jain at [email protected]. Follow Healio on X and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/. Follow Dr. Jain on X: @ShikhaJainMD. McBeth can be reached via email [email protected]. Learn more about ImpediMed at https://www.impedimed.com/, or follow them on LinkedIn or Instagram @impedimedhealth.

References • Pasket ED, et al. J Clin Oncol. 2012;doi:10.1200/JCO.2012.41.8574 • Schmitz KH, et al. J Natl Cancer Inst Monogr. 2025;doi:10.1093/jncimonographs/lgaf007. • Stout NL, et al. Cancer. 2012;doi:10.1002/cncr.27476.

Disclosures: Jain and McBeth report no relevant financial disclosures.

In this episode, host Shikha Jain, MD, speaks with Shakira Grant, MBBS, about providing patients and physicians with the proper education on AI tools, focusing on marginalized communities and more. • Welcome to another exciting episode of Oncology Overdrive 0:14 • About Grant 0:26 • The interview 2:07 • How did you get to where you are today? 2:38 • Tell me about how you got into the AI space […] What aspects interest you specifically? 4:19 • Can you take me step-by-step through how CROSS works with different health care organizations? 8:05 • How does CROSS address concerns about AI? 10:33 • Do you think AI could widen our disparities if it's taking its prompts from biases in humans? 13:31 • How do we educate people about fixing the challenges presented by AI so that we can use this data more accurately? 16:38 • Where do you see this going? […] What would you view as success in the next ten years? 18:22 • How are you managing the current political climate with this type of work? 21:31 • What do you plan to do next in your own career? 27:42 • If someone could only listen to the last few minutes of this episode, what would you want listeners to take away? 29:25 • How to contact Grant 30:23 • Thanks for listening 31:28

Shakira J. Grant, MBBS, MSCR, is a physician, entrepreneur, and healthcare executive who works at the intersection of clinical medicine, health policy, and artificial intelligence. She is the founder of CROSS Global Research & Strategy, LLC (CROSS), a company dedicated to providing end-to-end solutions that ease the adoption of AI in healthcare.

We'd love to hear from you! Send your comments/questions to Dr. Jain at [email protected]. Follow Healio on X and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/. Follow Dr. Jain on X: @ShikhaJainMD. Grant can be reached on LinkedIn or via email [email protected].

Disclosures: Jain and Grant report no relevant financial disclosures.

In this episode, host Shikha Jain, MD, speaks with James Hamrick, MD, and Sanjeev Kumar about the value of biomarker testing and precision oncology, personal journeys with patient advocacy and more. • Welcome to another exciting episode of Oncology Overdrive 1:05 • About Kumar 1:20 • About Hamrick 1:52 • The interview 2:30 • Sanjeev, can you tell us about how you got involved in oncology and immunology? 2:59 • James, how did you get into this space and start working with Caris Life Sciences? 7:15 • Sanjeev, how did your mother's experience unfold, and how did you incorporate your personal knowledge help advocate and navigate throughout the situation? 12:00 • Hamrick and Kumar on the importance of patient advocacy. 17:44 • Jain, Hamrick and Kumar on the impact precision oncology can have on personalized cancer care. 23:57 • How do we make current innovations available to everyone? How can we help advocate for patients in rural areas? 28:33 • Hamrick on how precision oncology helps support decision-making for physicians and community oncologists. 35:13 • Jain, Hamrick and Kumar on the art and practice of medicine. 40:57 • If someone could only listen to the last minute of this episode, what would you want listeners to take away? 41:53 • How to contact Kumar 44:13 • How to contact Hamrick 44:34 • Thanks for listening 45:14 James Hamrick, MD, MPH, is the chairman of the Caris Precision Oncology Alliance™ (Caris POA) at Caris Life Sciences.

Sanjeev Kumar is chairman and CEO of the Gallbladder Cancer Foundation, and is a biotech manufacturing leader with a background in immunology from UC Berkeley.

We'd love to hear from you! Send your comments/questions to Dr. Jain at [email protected]. Follow Healio on X and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/. Follow Dr. Jain on X: @ShikhaJainMD. Kumar can be reached via email at [email protected], or at the Gallbladder Cancer Foundation website. Hamrick can be reached at the Caris Life Sciences website.

Disclosures: Jain and Kumar report no relevant financial disclosures. Hamrick reports being an employee of Caris Life Sciences and an advisor to Community Oncology Partners LLC.

In this special edition episode, recorded live at the ASCO Annual Meeting, hosts Shikha Jain, MD, and Edward Kim, MD, honor Healio's 2025 Disruptive Innovators for their positive disruption in the field of hematology/oncology, and for pushing the status quo to improve clinical practice. • Welcome to the fourth annual Healio Disruptive Innovator Awards in hematology/oncology. 1:00 • VK Gadi, MD PhD, presents the Health Equity Award. 3:56 • The Health Equity Award winner, Ana Velázquez Mañana, MD, makes a speech. 6:00 • Morgan Collier presents the Woman Disruptor of the Year Award. 7:38 • Betty S. Pace, MD, accepts the Woman Disruptor of the Year Award. 9:19 • The Social Media Influencer Award, presented by Eleonora Teplinsky, MD. 11:53 • Amani Jambhekar, MD, also known as @ajvictorymd on Instagram and TikTok, accepts the Social Media Influencer Award. 13:13 • Brenda M. Nevidjon, MSN, RN, FAAN, presents the Advanced Practice Trailblazer Award. 14:40 • Ashley Leak Bryant, PhD, RN, OCN, FAAN, delivers her acceptance speech for the Advanced Practice Trailblazer Award. 16:19 • Kamal Jethwani, MD, MPH, presents the Patient Voice Award. 18:44 • Founder Kimberly Richardson, MA, accepts the Patient Voice Award for the Black Cancer Collaborative. 20:44 • Healio's chief content officer, Joan-Marie Stiglich, ELS, presents the NextGen Disruptor Award to Nazli Dizman, MD. 22:22 • The Clinical Innovation Award goes to UNC Lineberger Comprehensive Cancer Center for their at-home symptom reporting, led by Ethan Basch, MD, MSc. 24:18 • Hope S. Rugo, MD, wins the Lifetime Disruptor Award. 26:48 • The Industry Breakthrough Award goes to Breyanzi (lisocabtagene maraleucel, or liso-cel) from Bristol Myers Squibb. 30:57 • On behalf of Bristol Myers Squibb, Amy Corrao, MSN, NP-C, accepts the Industry Breakthrough Award. 32:33 • Thanks to all of the winners, nominees and sponsors! 35:39 • Thanks for listening. 36:21

We'd love to hear from you! Send your comments/questions to Dr. Jain at [email protected]. Follow Healio on X and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/. Follow Dr. Jain on X: @ShikhaJainMD. Read the full coverage from Healio's Disruptive Innovators here.

In this episode, host Shikha Jain, MD, speaks with Mika Stambaugh about bridging the patient and doctor information gap, her personal journey with patient advocacy and more. • Welcome to another exciting episode of Oncology Overdrive 1:34 • About Stambaugh 1:43 • The interview 4:00 • How did you get into media and PR? […] What Was your journey to get to this point in your career? 4:31 • Have you seen the evolution of people in health care speaking with the media? 6:57 • How do you remain objective when discussing hot button political topics with experts? 10:05 • Who is the coolest or most interesting person you have interviewed? 11:08 • Can you tell us about your recent cancer diagnosis and how it impacted you? 13:25 • How did your facial Mohs surgery impact your career? 18:39 • What was it about this situation that made you decide to share your journey publicly? 24:11 • Do you recommend getting a second opinion to people? How did the decision to seek out a second opinion come about for you? 27:57 • Do you see yourself continuing to work in the patient advocacy space? 30:35 • If someone could only listen to the last minute of this episode, what would you want listeners to take away? 36:50 • How to contact Stambaugh 37:55 • Thanks for listening 39:05 Mika Stambaugh is an Emmy award winning journalist and dynamic entrepreneur.

We'd love to hear from you! Send your comments/questions to Dr. Jain at [email protected]. Follow Healio on X and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/. Follow Dr. Jain on X: @ShikhaJainMD. Stambaugh can be reached @MikaStambaugh on X and @mikastambaugh on Instagram, or via email [email protected].

Disclosures: Jain and Stambaugh report no relevant financial disclosures.

In this episode, host Shikha Jain, MD, speaks with Elisabeth Potter, MD, about physicians pushing back against insurance companies, bringing physicians back into positions of autonomy and more. • Welcome to another exciting episode of Oncology Overdrive 1:34 • About Potter 1:41 • The interview 2:04 • How did you decide to become a plastic surgeon? What was your path? 2:26 • How many years do you have to train for plastic surgery? 3:36 • What kind of physician is your father? […] Did you ever think you wanted to practice in the same field as him? 4:10 • Can you tell us about what happened that led you to post your recent viral video? 6:11 • Have you noticed an increase in insurance obstacles lately, or has it always been this way? 8:45 • When you talk to insurance companies, do you feel like you speak with someone who is qualified to understand these claims? 10:06 • Other than hiring people to deal with insurance claims, how can we work towards actually driving change in this space? 12:11 • Jain and Potter on the value of physicians knowing their worth and the cost of their care/procedures. 16:03 • Jain and Potter on the importance of physician autonomy. 23:21 • Potter and Jain on the changing national dialogue. 28:48 • When it comes to direct care models, how would patients be able to get second opinions? 33:53 • Are you optimistic that we will be able to realistically drive change? 35:37 • What do you suggest physicians, patients and advocates do to raise their voices and be heard? 35:56 • If someone could only listen to the last minute of this episode, what would you want listeners to take away? 40:14 • How to contact Potter 40:41 • Thanks for listening 41:38 Elisabeth Potter, MD, is a board-certified plastic surgeon offering a variety of plastic surgery, ranging from breast reconstruction to breast and body cosmetic procedures.

We'd love to hear from you! Send your comments/questions to Dr. Jain at [email protected]. Follow Healio on X and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/. Follow Dr. Jain on X: @ShikhaJainMD. Potter can be reached on Instagram @drelisabethpotter, TikTok @drelisabethpotter and YouTube @DrElisabethPotterMD.

Disclosures: Jain and Potter report no relevant financial disclosures.

In this episode, host Shikha Jain, MD, speaks with Don Dizon, MD, about innovation throughout times of uncertainty in medicine, challenges currently facing physicians and more. • Welcome to another exciting episode of Oncology Overdrive 1:34 • About Dizon 1:44 • The interview 2:27 • How did you decide to become an oncologist and navigate a traditional academic career with many non-traditional "add-ons"? 3:01 • Jain and Dizon on the importance of providing humanity to physicians. 7:19 • Jain and Dizon on finding balance when providing patients with information. 9:03 • Jain and Dizon on federal funding challenges facing oncology advancements. 10:17 • Can you tell us more about transitioning to your new role at Tufts? 12:50 • Jain and Dizon on the growing amount of career shifts in medicine. 17:22 • How do we move forward with these new guardrails up from corporatization? 18:34 • Jain and Dizon on how the age of social media has changed the perception, training and demands of doctors. 24:56 • Dizon and Jain on the power of being able to admit "I don't know." 28:22 • What are some tips that you have for new attendings and people just starting in their careers? 33:54 • Dizon and Jain on the importance of humanizing patients during their care. 38:34 • If someone could only listen to the last few minutes of this episode, what would you want listeners to take away? 44:17 • How to contact Dizon 44:57 • Thanks for listening 45:51 Don Dizon, MD, is a professor of medicine at Tufts University and is the system chief of hematology and oncology for Tufts Medicine. He is also the editor in chief of CA: A Cancer Journal for Clinicians, the flagship journal of the American Cancer Society as well as the vice-chair of membership and accrual at the SWOG Cancer Research Network.

We'd love to hear from you! Send your comments/questions to Dr. Jain at [email protected]. Follow Healio on X and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/. Follow Dr. Jain on X: @ShikhaJainMD. Dizon can be reached on Tiktok @drdonsdizon, Instagram @drdonsdizon and LinkedIn.

Disclosures: Jain and Dizon report no relevant financial disclosures.

In this episode, recorded live at the 2025 ASCO annual meeting, host Shikha Jain, MD, speaks with Sonali Smith, MD, about the power of mentorship and advocacy, preserving the academic mission of research within health care systems and more. • Welcome to another exciting episode of Oncology Overdrive 1:34 • About Smith 1:56 • The interview 3:14 • What was your journey to get to where you are now in your career? 3:38 • How do you incorporate your advocacy work into patient care, and how do you advise other physicians on their advocacy journeys? 12:09 • Jain and Smith on how the politicization of health care has resulted in the rise of and demand for public physician advocacy. 13:32 • Jain and Smith on the impacts of today's climate on clinical research work. 18:24 • Can you speak about your ELAM capstone project discussing how to preserve academics? 25:11 • Are there any lymphoma studies presented at ASCO this year that have excited you or interested/educated you? 31:54 • Jain and Smith on how ASCO underlines the importance of international collaboration in oncology research. 36:46 • If someone could only listen to the last few minutes of this episode, what would you want listeners to take away? 39:47 • How to contact Smith 40:27 • Thanks for listening 41:03 Sonali M. Smith, MD, is the Elwood V. Jensen professor of medicine, section chief of hematology/oncology, co-leader of the cancer service line, and co-director of the lymphoma program at the University of Chicago in the department of medicine. She is a clinical investigator in lymphoma and a clinical expert in Hodgkin and non-Hodgkin lymphomas.

We'd love to hear from you! Send your comments/questions to Dr. Jain at [email protected]. Follow Healio on X and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/. Follow Dr. Jain on X: @ShikhaJainMD. Smith can be reached on LinkedIn or via email [email protected].

Disclosures: Jain and Smith report no relevant financial disclosures.

In this episode, host Shikha Jain, MD, speaks with Sadie Dobrozsi, MD, about the power of information in personalized oncology care, understanding the impacts of genetic testing and more. • Welcome to another exciting episode of Oncology Overdrive 1:34 • About Dobrozsi 1:39 • The interview 2:03 • What was your path to this field of pediatric oncology, and how did you decide to focus on genetic testing? 2:33 • Can you talk about what it means to use genomics to optimize therapy and tailor precision medicine, and how you implement that in your work? 7:58 • Why is it so important to continue focusing on funding precision medicine as an advancement in cancer care? 10:34 • Can you talk about your work with BRCA research and how treatment and surgeries have evolved with our understanding of it? 14:30 • Jain and Dobrozsi on the importance of shared decision-making in oncology, and how genomics plays a role in that ongoing conversation. 20:18 • How do we navigate difficult conversations with increasingly younger patient populations, and why are we having these conversations more now than ever before? 23:55 • When it comes to genetic testing, how much knowledge is "good knowledge"? 27:05 • If someone could only listen to the last few minutes of this episode, what would you want listeners to take away? 34:31 • How to contact Dobrozsi 35:12 • Thanks for listening 35:39 Sadie Dobrozsi, MD, is a board-certified pediatric oncologist, a nationally recognized leader in complex care delivery, and the medical director of genetic testing and oncology imaging at Evolent, a leading specialty and primary care management company.

We'd love to hear from you! Send your comments/questions to Dr. Jain at [email protected]. Follow Healio on X and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/. Follow Dr. Jain on X: @ShikhaJainMD. Dobrozsi can be reached on LinkedIn or via email [email protected].

Disclosures: Jain and Dobrozsi report no relevant financial disclosures.

In this episode, host Shikha Jain, MD, speaks with Abiola Ibraheem, MD, about the role culture plays in improving global oncology, launching the Best of ASCO in Africa and more. • Welcome to another exciting episode of Oncology Overdrive 1:34 • About Ibraheem 1:42 • The interview 3:02 • How did you get where you are today? 3:28 • Can you tell me more about Aortic Africa and your role within the organization? 5:41 • What are some challenges you have encountered in doing this work, both locally and internationally? 7:33 • How have you navigated the nuances of global oncology in other countries? 9:51 • Did you get any pushback when you decided to create these global relationships and inroads? How did you navigate receiving different perspectives on your work? 12:10 • What are you hoping to achieve with these efforts in global oncology? 16:28 • Where did the idea for a Best of ASCO Africa come from, and what do you hope to achieve with the event? 17:41 • Jain and Ibraheem on the importance of providing other countries with tools to implement and drive global change. 22:54 • If someone could only listen to the last few minutes of this episode, what would you want listeners to take away? 27:29 • How to contact Ibraheem 28:09 • Thanks for listening 29:07 Abiola Ibraheem, MD, is a board-certified medical oncologist and assistant professor at the University of Illinois Chicago. Her journey in medicine began in Nigeria, where she earned her MBBS degree from Olabisi Onabanjo University. She then completed her internal medicine residency at Morehouse School of Medicine, focusing on racial health care disparities.

We'd love to hear from you! Send your comments/questions to Dr. Jain at [email protected]. Follow Healio on X and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/. Follow Dr. Jain on X: @ShikhaJainMD. Ibraheem can be reached via email at [email protected].

Learn more about Best of ASCO Africa, as well as how to sign up for in-person or virtual attendance, happening June 27 & 28 in Addis Abba, Ethiopia.

Disclosures: Jain and Ibraheem report no relevant financial disclosures.